HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

Association of antigen processing machinery and HLA class I defects with clinicopathological outcome in cervical carcinoma.

AbstractHLA class I loss is a significant mechanism of immune evasion by cervical carcinoma, interfering with the development of immunotherapies and cancer vaccines. We report the systematic investigation of HLA class I and antigen processing machinery component expression and association with clinical outcome. A tissue microarray containing carcinoma lesions from 109 cervical carcinoma patients was stained for HLA class I heavy chains, beta(2)-microglobulin, LMP2, LMP7, LMP10, TAP1, TAP2, ERAP1, tapasin, calreticulin, calnexin and ERp57. A novel staining evaluation method was used to ensure optimal accuracy and reliability of expression data, which were correlated with known clinicopathological parameters. Partial HLA class I loss was significantly associated with decreased 5-years overall survival (61% vs. 83% for normal expression; P<0.05) and was associated with decreased 5-years disease-free survival (DFS) (65% vs. 82% for normal expression; P=0.05). All APM components except LMP10, calnexin and calreticulin were down-regulated in a substantial number of cases and, except ERAP1, correlated significantly with HLA class I down-regulation. LMP7, TAP1 and ERAP1 loss was significantly associated with decreased overall and (except LMP7) DFS (P<0.05 and 0.005, respectively). ERAP1 down-regulation was an independent predictor for worse overall and DFS in multivariate analysis (HR 3.08; P<0.05 and HR 2.84; P<0.05, respectively). HLA class I and APM component down-regulation occur frequently in cervical carcinoma, while peptide repertoire alterations due to ERAP1 loss are a major contributing factor to tumour progression and mortality.
AuthorsAkash M Mehta, Ekaterina S Jordanova, Gemma G Kenter, Soldano Ferrone, Gert-Jan Fleuren (Affiliation: Department of Pathology, Leiden University Medical Centre, P1-40, L1-Q, 2333 ZA Leiden, The Netherlands.)
JournalCancer immunology, immunotherapy : CII (Cancer Immunol Immunother) Vol. 57 Issue 2 Pg. 197-206 (Feb 2008) ISSN: 0340-7004 [Print] Germany
PMID17622526 (Publication Type: Journal Article)
Chemical References
  • ARTS-1 protein, human
  • ATP-Binding Cassette Transporters
  • Histocompatibility Antigens Class I
  • TAP1 protein, human
  • Aminopeptidases
Topics
  • ATP-Binding Cassette Transporters (metabolism)
  • Adult
  • Aged
  • Aged, 80 and over
  • Aminopeptidases (metabolism)
  • Antigen Presentation (immunology)
  • Disease-Free Survival
  • Down-Regulation
  • Female
  • Histocompatibility Antigens Class I (metabolism)
  • Humans
  • Immunohistochemistry
  • Kaplan-Meiers Estimate
  • Middle Aged
  • Prognosis
  • Tissue Array Analysis
  • Uterine Cervical Neoplasms (immunology, mortality, pathology)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!


Choose Username:
Email:
Password:
Verify Password:


Research Interface PRO additionally includes drill-down to evidence, articles by author, export to Excel, FDA Link and mobile subscription:
1 year subscription, $45.00 USD